Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC). (December 2016)
- Record Type:
- Journal Article
- Title:
- Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC). (December 2016)
- Main Title:
- Galunisertib combined with sorafenib affects in vivo tumor growth and immune landscape in hepatocellular carcinoma (HCC)
- Authors:
- Tijeras-Raballand, A.
Le Bitoux, M.A.
Maillard, A.
Albuquerque, M.
Colnot, N.
Barral, M.
Dohan, A.
Bonnin, P.
Pocard, M.
Benhadji, K.
Paradis, V.
Raymond, E.
Harari, A.
Faivre, S.
De Gramont, A. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 69(2016)supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 69(2016)supplement 1
- Issue Display:
- Volume 69, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 69
- Issue:
- 2016
- Issue Sort Value:
- 2016-0069-2016-0000
- Page Start:
- S133
- Page End:
- Publication Date:
- 2016-12
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(16)32996-3 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2628.xml